Industry Updates for the Psychedelics World | Page 25 of 35

Psychedelics News

Industry

30 Jun 2022

Red Light Holland Signs Deal with Wiz Khalifa to Launch Mushroom Brand

Red Light Holland has added another big name to their creative form of psychedelic entrepreneurism by signing a deal with hip hop superstar Wiz Khalifa....

By Microdose NewsDesk

Industry

29 Jun 2022

Psychedelics and VR: Exploring New Horizons in Therapeutics and IP

A new generation of researchers are combining virtual reality and psychedelics to create new therapeutic paradigms that improve patient care and are also filing patents to capture their innovation....

By Jayashree Mitra

Industry

28 Jun 2022

Ceruvia Receives FDA Approval for Phase 2 OCD Trial

The FDA has given the green light to start a Phase 2 clinical trial to determine the efficacy and safety of Ceruvia’s synthetic psilocybin (SYNP-101) in treating obsessive-compulsive disorder (OCD)....

By Jason Najum

Industry

27 Jun 2022

Cybin Receives FDA Clearance for Phase 1/2a Trial

Cybin Receives FDA IND Clearance for its Phase 1/2a Clinical Trial Evaluating CYB003 for the Potential Treatment of Major Depressive Disorder...

By Microdose NewsDesk

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

24 Jun 2022

Wonder Sciences Launches Wondermed At-Home Ketamine Treatments

There's a new player on the at-home scene, with Wondermed launching its own at-home ketamine service....

By Microdose NewsDesk

Industry, Science

22 Jun 2022

New DMT Study Shows Positive Results for Depression

A new study published in Nature has a variety of interesting results for the use of DMT, showing positive results for depression and potential for easier patient access....

By Jason Najum

Industry

20 Jun 2022

FDA Clears Mydecine’s MYCO-001 for Government Funded Trial

The trial is funded by a near $4 million grant from the National Institutes of Health, making this the first time in 50 years the U....

By Microdose NewsDesk

Industry

17 Jun 2022

Top Clinical Trials in 2022 (Part 2)

The success or failure of the sector’s advanced clinical trials will dictate the future of the industry....

By Jason Najum

Industry, Press Releases

13 Jun 2022

Launch of the Psychedelic Access and Research European Alliance – PAREA

PAREA is a non-profit, multistakeholder and multidisciplinary partnership bringing together patient organizations, medical associations, scientific societies, psychedelic foundations, and the for-profit sector....

By Microdose

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result